J0665 HCPCS Level II code: Injection, bupivicaine, not otherwise specified, 0.5 mg
J0665 is the HCPCS code for “Injection, bupivicaine, not otherwise specified, 0.5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0665Injection, bupivicaine, not otherwise specified, 0.5 mg
Short description: Inj, bupivacaine, nos, 0.5mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0665 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jul 1, 2023
Where J0665 sits
- 1J codesDrugs administered other than orally
- 2Active code J0665Injection, bupivicaine, not otherwise specified, 0.5 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0665 mean?
J0665 is the HCPCS code for “Injection, bupivicaine, not otherwise specified, 0.5 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0665?
CMS lists J0665’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0665
All J codesJ0643Injection, leucovorin calcium, not otherwise specified, 1 mgJ0644Injection, leucovorin calcium (avyxa), 1 mgJ0650Injection, levothyroxine sodium, not otherwise specified, 10 mcgJ0651Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcgJ0652Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcgJ0654Injection, liothyronine, 1 mcgJ0666Injection, bupivacaine liposome, 1 mgJ0668Instillation, bupivacaine and meloxicam, 1 mg/0.03 mgJ0670Injection, mepivacaine hydrochloride, per 10 mlJ0675Injection, carboprost tromethamine, 0.1 mgJ0681Injection, ceftobiprole medocaril sodium, 3 mgJ0687Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg